Wai Conrad
Officer at CLOV
- Sold, on record
- $3.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Sep 15, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CLOVCLOVER HEALTH INVESTMENTS, CORP. /DEOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice CLOVNoticeJul 8, 2025 2025
Filed to sell 225,000 shares ($731k)
Wai Conrad, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale CLOVRoutineJul 23, 2025 +15 days
Sold 209,797 shares at $3.30 ($693k)
Wai Conrad, CEO, Counterpart Health
10b5-1 planSold 13% of holdings ($5.3M position)1.4M shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice CLOVNoticeMay 28, 2026 +309 days
Filed to sell 220,426 shares ($881k)
Wai Conrad, Officer
10b5-1 planFiling
- 4 Form 4 sale CLOVRoutineMay 28, 2026 same day
Sold 220,426 shares at $3.99 ($879k)
Wai Conrad, CEO, Counterpart Health
10b5-1 planSold 13.7% of holdings ($6.4M position)1.4M shares leftFollows a Form 144Filing
- 5 Form 144 notice CLOVNoticeJul 15, 2026 +48 days
Filed to sell 23,463 shares ($110k)
Wai Conrad, Officer
10b5-1 planFiling
- 6 Form 4 sale CLOVRoutineJul 15, 2026 same day
Sold 24,215 shares at $4.67 ($113k)
Wai Conrad, CEO, Counterpart Health
10b5-1 planSold 2.1% of holdings ($5.5M position)1.1M shares leftFollows a Form 144Filing
- 7 Form 144 notice CLOVNoticeSep 15, 2026 +62 days
Filed to sell 300,000 shares ($1.4M)
Wai Conrad, Officer
10b5-1 plan1.4x usual sizeFiling
- 8 Form 4 sale CLOVRoutineSep 15, 2026 same day
Sold 300,000 shares at $4.72 ($1.4M)
Wai Conrad, CEO, Counterpart Health
10b5-1 planSold 20.4% of holdings ($6.9M position)1.2M shares left1.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 16, 2026 | CLOV | CEO, Counterpart Health | Form 4 sale | 300,000 | $1.4M | 20.4% | Routine | SEC |
| Sep 15, 2026 | Sep 15, 2026 | CLOV | Officer | Form 144 notice | 300,000 | $1.4M | Notice | SEC | |
| Jul 15, 2026 | Jul 16, 2026 | CLOV | CEO, Counterpart Health | Form 4 sale | 24,215 | $113k | 2.1% | Routine | SEC |
| Jul 15, 2026 | Jul 15, 2026 | CLOV | Officer | Form 144 notice | 23,463 | $110k | Notice | SEC | |
| May 28, 2026 | May 28, 2026 | CLOV | CEO, Counterpart Health | Form 4 sale | 220,426 | $879k | 13.7% | Routine | SEC |
| May 28, 2026 | May 28, 2026 | CLOV | Officer | Form 144 notice | 220,426 | $881k | Notice | SEC | |
| Jul 23, 2025 | Jul 24, 2025 | CLOV | CEO, Counterpart Health | Form 4 sale | 209,797 | $693k | 13.0% | Routine | SEC |
| Jul 8, 2025 | Jul 8, 2025 | CLOV | Officer | Form 144 notice | 225,000 | $731k | Notice | SEC |